Last 12 months
Inside the activity.
14 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 8 | 5 |
| Apr 2026 | 2 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 7,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246921 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,816 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC |
CONLEY SHERYL LDirector
|
GrantCommon Stock | 7,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246922 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,716 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 10,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246923 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 588,767 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC |
Cucuz SashaDirector
|
GrantCommon Stock | 6,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246920 · ownership.xml · nonDerivative · entry 1 Cucuz Sasha · CIK 0002004858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,512,798 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
MADRYN SELECT ADVISORS, LP10% owner
MADRYN SELECT ADVISORS GP, LLC10% owner
|
SaleCommon Stock | 381,640 | $3.72 | $1,419,700.80 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,261,168 F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F5 · ownership.nature: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
MADRYN SELECT ADVISORS, LP10% owner
MADRYN SELECT ADVISORS GP, LLC10% owner
|
SaleCommon Stock | 2,925,554 | $3.72 | $10,883,060.88 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 17,333,542 F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F4 · ownership.nature: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
MADRYN SELECT ADVISORS, LP10% owner
MADRYN SELECT ADVISORS GP, LLC10% owner
|
SaleCommon Stock | 192,806 | $3.72 | $717,238.32 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,142,351 F1 · ownership.nature: Represents shares of common stock held by Madryn Health Partners II, LP ("Health Partners"), for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| July 15, 2025 Filed Jul 15, 2025 21:00 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095914 · ownership.xml · nonDerivative · entry 2 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F3 · shares: Represents a RSU award that vests in three equal annual installments beginning on July 15, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 15, 2025 Filed Jul 15, 2025 21:00 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095914 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on July 15, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 10, 2025 Filed Apr 1, 2026 20:57 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
|
GiftCommon Stock | 337,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138142 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 17,044,940 F1 · price: The reported transactions involved a transfer of shares for no consideration between Madryn Health Partners II, LP ("Health Partners") and Madryn Health Partners II (Cayman Master), LP ("Cayman Master") for fund administration purposes. F2 · balance_after: Represents shares of common stock held as of the date of filing of this Form 4. F4 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master; and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners and Cayman Master, respectively. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F6 · ownership.nature: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. Read SEC document |
| July 10, 2025 Filed Apr 1, 2026 20:57 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
|
GiftCommon Stock | 337,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138142 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,430,953 F1 · price: The reported transactions involved a transfer of shares for no consideration between Madryn Health Partners II, LP ("Health Partners") and Madryn Health Partners II (Cayman Master), LP ("Cayman Master") for fund administration purposes. F2 · balance_after: Represents shares of common stock held as of the date of filing of this Form 4. F3 · ownership.nature: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F4 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master; and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners and Cayman Master, respectively. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
Amin AvinashDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077826 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077824 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,262 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
CONLEY SHERYL LDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077827 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,390 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
Rosengarten MeganDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077829 · ownership.xml · nonDerivative · entry 1 Rosengarten Megan · CIK 0001876577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,890 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 36,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077828 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,236 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC |
Cucuz SashaDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077825 · ownership.xml · nonDerivative · entry 1 Cucuz Sasha · CIK 0002004858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,506,388 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 13, 2025 Filed May 14, 2025 17:05 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 6,540 | $4.16 | $27,206.40 |
DisclosureSEC source: 0000950170-25-071591 · ownership.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,053 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.17 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2025 Filed May 14, 2025 17:05 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 193,460 | $4.27 | $826,074.20 |
DisclosureSEC source: 0000950170-25-071591 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,593 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.46 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 17:00 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 1,867 | $4.48 | $8,364.16 |
DisclosureSEC source: 0000950170-25-034871 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,053 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.72 to $4.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:00 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
SaleCommon Stock | 377 | $4.48 | $1,688.96 |
DisclosureSEC source: 0000950170-25-034868 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,805 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.72 to $4.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 17:46 UTC |
Furlong StephenEVP, CFO and Treasurer
|
GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028002 · ownership.xml · derivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 17:46 UTC |
Furlong StephenEVP, CFO and Treasurer
|
GrantCommon Stock | 157,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028002 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 611,920 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:49 UTC |
Sullivan Keith JDirector · President and CEO
|
GrantPerformance Restricted Stock Unit · Derivative | 187,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028008 · ownership.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to recieve one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to recieve one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:49 UTC |
Sullivan Keith JDirector · President and CEO
|
GrantCommon Stock | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028008 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607,988 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:48 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028006 · ownership.xml · derivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:48 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
GrantCommon Stock | 157,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028006 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,182 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 17:28 UTC Amendment |
Furlong StephenEVP, CFO and Treasurer
|
GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038909 · ownership.xml · derivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 21:30 UTC Amendment |
Sullivan Keith JDirector · President and CEO
|
GrantPerformance Restricted Stock Unit · Derivative | 187,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038913 · ownership.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 21:24 UTC Amendment |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038901 · ownership.xml · derivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:21 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 24,440 | $4.70 | $114,868.00 |
DisclosureSEC source: 0000950170-25-024308 · ownership.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232,988 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.60 to $4.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:21 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 25,934 | $4.41 | $114,368.94 |
DisclosureSEC source: 0000950170-25-024308 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,257,428 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.29 to $4.55. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 17:02 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 17,307 | $4.11 | $71,131.77 |
DisclosureSEC source: 0000950170-25-022428 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,420 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.99 to $4.27. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 22:03 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
SaleCommon Stock | 18,965 | $4.11 | $77,946.15 |
DisclosureSEC source: 0000950170-25-022433 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,682 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.99 to $4.27. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 17:00 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 10,845 | $3.83 | $41,536.35 |
DisclosureSEC source: 0000950170-25-021398 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,727 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.74 to $3.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:00 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
SaleCommon Stock | 12,175 | $3.83 | $46,630.25 |
DisclosureSEC source: 0000950170-25-021391 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,647 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.74 to $3.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 17:05 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 14,836 | $3.28 | $48,662.08 |
DisclosureSEC source: 0000950170-25-018967 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,572 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:05 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 40,992 | $3.28 | $134,453.76 |
DisclosureSEC source: 0000950170-25-018968 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,283,362 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:05 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
SaleCommon Stock | 1,970 | $3.28 | $6,461.60 |
DisclosureSEC source: 0000950170-25-018969 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,822 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:18 UTC |
MUIR GLENN PDirector
|
OtherCommon Stock | 44,444 | $2.25 | $99,999.00 |
DisclosureSEC source: 0000950170-25-017195 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,262 F1 · kind: On February 7, 2025, the Reporting Person purchased 44,444 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:20 UTC |
CONLEY SHERYL LDirector
|
OtherCommon Stock | 44,444 | $2.25 | $99,999.00 |
DisclosureSEC source: 0000950170-25-017198 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,390 F1 · kind: On February 7, 2025, the Reporting Person purchased 44,444 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:16 UTC |
Cucuz SashaDirector
|
OtherCommon Stock | 88,888 | $2.25 | $199,998.00 |
DisclosureSEC source: 0000950170-25-017193 · ownership.xml · nonDerivative · entry 1 Cucuz Sasha · CIK 0002004858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,476,388 F1 · kind: On February 7, 2025, the Reporting Person purchased 88,888 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:13 UTC |
CASCELLA ROBERTDirector
|
OtherCommon Stock | 88,888 | $2.25 | $199,998.00 |
DisclosureSEC source: 0000950170-25-017184 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,986 F1 · kind: On February 7, 2025, the Reporting Person purchased 88,888 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 17:00 UTC |
Furlong StephenEVP, CFO and Treasurer
|
GrantPerformance Restricted Stock Unit · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135873 · ownership.xml · derivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:00 UTC |
Sullivan Keith JDirector · President and CEO
|
GrantPerformance Restricted Stock Unit · Derivative | 450,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135877 · ownership.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:00 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
GrantPerformance Restricted Stock Unit · Derivative | 135,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135874 · ownership.xml · derivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 17:05 UTC |
Furlong StephenEVP, CFO and Treasurer
|
SaleCommon Stock | 1,368 | $0.82 | $1,121.76 |
DisclosureSEC source: 0000950170-24-114103 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,408 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.78 to $0.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 21:05 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
SaleCommon Stock | 1,541 | $0.82 | $1,263.62 |
DisclosureSEC source: 0000950170-24-114102 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,792 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.78 to $0.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 21:02 UTC |
CASCELLA ROBERTDirector
|
PurchaseCommon Stock | 100,000 | $0.75 | $75,000.00 |
DisclosureSEC source: 0000950170-24-106434 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,098 Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 21:05 UTC |
MUIR GLENN PDirector
|
PurchaseCommon Stock | 25,000 | $0.80 | $20,000.00 |
DisclosureSEC source: 0000950170-24-104427 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,818 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.